We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+3.49%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
AUM
$6.26B
AUM Growth
+$473M
Cap. Flow
+$398M
Cap. Flow %
6.35%
Top 10 Hldgs %
23.68%
Holding
293
New
38
Increased
125
Reduced
71
Closed
38

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$48.5M
2
MRK icon
Merck
MRK
+$37.3M
3
AMGN icon
Amgen
AMGN
+$35M
4
EW icon
Edwards Lifesciences
EW
+$29.3M
5
BAH icon
Booz Allen Hamilton
BAH
+$26.3M

Sector Composition

Rank Sector Weight
1 Financials 23.24%
2 Technology 21.39%
3 Healthcare 21.13%
4 Communication Services 9.82%
5 Industrials 4.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFPT
51
DELISTED
Proofpoint, Inc.
PFPT
$33.8M 0.54%
478,427
+62,052
+15% +$4.67M
ADBE icon
52
Adobe
ADBE
$89.5B
$33.6M 0.54%
326,496
+4,601
+1% +$487K
ESNT icon
53
Essent Group
ESNT
$6.06B
$33.1M 0.53%
1,021,200
+196,200
+24% +$5.78M
ZEN
54
DELISTED
ZENDESK INC
ZEN
$33M 0.53%
1,557,039
+633,139
+69% +$15.3M
AMD icon
55
CALL
Advanced Micro Devices
AMD
$851B
$32.9M 0.52%
2,897,300
-965,700
-25% -$8.1M
LH icon
56
Labcorp
LH
$24.3B
$30.9M 0.49%
280,524
+79,152
+39% +$8.79M
RGA icon
57
Reinsurance Group of America
RGA
$15.7B
$30.8M 0.49%
245,100
+37,600
+18% +$4.41M
CRM icon
58
Salesforce
CRM
$134B
$30.8M 0.49%
449,959
+78,333
+21% +$5.68M
CYBR
59
DELISTED
CyberArk
CYBR
$30.6M 0.49%
673,105
+4,099
+0.6% +$200K
DHR icon
60
Danaher
DHR
$135B
$29.9M 0.48%
433,716
+21,996
+5% +$1.53M
SPNC
61
DELISTED
Spectranetics Corp
SPNC
$29M 0.46%
1,185,000
+75,000
+7% +$1.76M
DLB icon
62
Dolby
DLB
$4.72B
$29M 0.46%
641,330
+106,383
+20% +$5.13M
EA icon
63
Electronic Arts
EA
$52.4B
$28.4M 0.45%
360,643
-59,292
-14% -$4.77M
NTES icon
64
NetEase
NTES
$76.5B
$28.3M 0.45%
657,545
+87,700
+15% +$4.19M
WRB icon
65
W.R. Berkley
WRB
$28B
$28.2M 0.45%
1,432,688
+487,688
+52% +$8.76M
AGCO icon
66
AGCO
AGCO
$8.78B
$27.7M 0.44%
479,376
+4,456
+0.9% +$241K
BCR
67
DELISTED
CR Bard Inc.
BCR
$27.4M 0.44%
121,991
-15,545
-11% -$3.38M
RNR icon
68
RenaissanceRe
RNR
$13.7B
$27.3M 0.44%
200,200
+52,700
+36% +$6.75M
FIS icon
69
Fidelity National Information Services
FIS
$21.5B
$27M 0.43%
357,559
-1,775
-0.5% -$135K
MD icon
70
Pediatrix Medical
MD
$2.16B
$26.9M 0.43%
+404,194
New +$26.3M
RVNC
71
DELISTED
Revance Therapeutics, Inc.
RVNC
$26.8M 0.43%
1,296,371
-23,500
-2% -$394K
RHT
72
DELISTED
Red Hat Inc
RHT
$26.6M 0.42%
381,669
+22,590
+6% +$1.74M
IPG
73
DELISTED
Interpublic Group of Companies
IPG
$26.4M 0.42%
+1,129,025
New +$26.1M
QVCGA
74
DELISTED
QVC Group Inc Series A
QVCGA
$26.1M 0.42%
26,889
-465
-2% -$449K
AMG icon
75
Affiliated Managers Group
AMG
$9.46B
$26.1M 0.42%
179,459
+41,454
+30% +$6.02M

Similar funds

Polar Capital's Q4 2016 Portfolio in Review

As of Q4 2016, Polar Capital held 293 positions worth $6.26B, up 8.2% from $5.79B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Polar Capital deployed $398M of net new capital in Q4 2016, opening 38 new positions and adding to 125 existing holdings. Its largest new stake was Aetna Inc: 279,500 shares worth $34.7M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $48.5M trimmed.

  • Polar Capital's largest Q4 2016 buy was Aetna Inc: 279,500 shares worth $34.7M.
  • Polar Capital added most to Alexion Pharmaceuticals in Q4 2016, an estimated $53.8M increase.
  • Polar Capital's biggest Q4 2016 reduction was Johnson & Johnson, cutting an estimated $48.5M.
  • Polar Capital fully exited Edwards Lifesciences in Q4 2016, selling an estimated $29.3M.
  • Polar Capital's ten largest holdings make up 24% of its $6.26B portfolio in Q4 2016.
  • Polar Capital opened 38 new positions and closed 38 in Q4 2016.
  • Polar Capital's portfolio value rose 8.2% quarter-over-quarter to $6.26B.

Based on Polar Capital's 13F filing for Q4 2016, filed 14 Feb 2017.